Literature DB >> 9599359

Physical and psychosocial outcomes of midlife and older women following surgery and adjuvant therapy for breast cancer.

G K Wyatt1, L L Friedman.   

Abstract

PURPOSE/
OBJECTIVES: To investigate the patterns of functioning and psychosocial adjustment of midlife and older women following surgery for breast cancer. Differences between those who received follow-up adjuvant therapy and those who did not also were compared.
DESIGN: 2 x 3 mixed design with one between-groups factor (type of treatment) and one within-subjects factor (time).
SETTING: Four midwestern hospitals. SAMPLE: 46 patients with breast cancer who are age 55 or older.
METHODS: Baseline data about presurgical functional status and other variables were obtained during the first week after surgery. Follow-up data were obtained at six weeks, three months, and six months postsurgery. Data were collected via telephone interviews and mailed questionnaires. MAIN RESEARCH VARIABLES: Functional status, patient symptomatology, quality of life (QOL), demands of illness, and type of treatment (surgery only versus surgery plus adjuvant therapy).
FINDINGS: No differences existed between the two treatment groups at baseline, with the exception of lower functional status reported by the surgery-only group. In the surgery-only group, functional status improved significantly from six weeks to three months postsurgery. The most frequently reported symptoms of both groups included fatigue and pain.
CONCLUSIONS: These results suggest that both groups did equally well, regardless of whether they received adjuvant therapy (radiation or chemotherapy). Neither QOL nor demands of illness differed between the two groups, nor did these scores change significantly over time following surgery. IMPLICATIONS FOR NURSING PRACTICE: These findings suggest that women undergoing surgery for breast cancer, whether they receive adjuvant therapy or not, may have functional and psychosocial needs that could be effectively addressed by nursing interventions pre- and postsurgery.

Entities:  

Mesh:

Year:  1998        PMID: 9599359

Source DB:  PubMed          Journal:  Oncol Nurs Forum        ISSN: 0190-535X            Impact factor:   2.172


  7 in total

1.  Presurgery psychological factors predict pain, nausea, and fatigue one week after breast cancer surgery.

Authors:  Guy H Montgomery; Julie B Schnur; Joel Erblich; Michael A Diefenbach; Dana H Bovbjerg
Journal:  J Pain Symptom Manage       Date:  2010-06       Impact factor: 3.612

2.  Variations in COMT and NTRK2 Influence Symptom Burden in Women Undergoing Breast Cancer Treatment.

Authors:  Erin E Young; Debra Lynch Kelly; Insop Shim; Kyle M Baumbauer; Angela Starkweather; Debra E Lyon
Journal:  Biol Res Nurs       Date:  2017-02-16       Impact factor: 2.522

3.  Older women, breast cancer, and social support.

Authors:  Grace J Yoo; Ellen G Levine; Caryn Aviv; Cheryl Ewing; Alfred Au
Journal:  Support Care Cancer       Date:  2009-11-22       Impact factor: 3.603

4.  Factors associated with fatigue after surgery in women with early-stage invasive breast cancer.

Authors:  Christine Rotonda; Francis Guillemin; Franck Bonnetain; Michel Velten; Thierry Conroy
Journal:  Oncologist       Date:  2013-02-12

5.  Predictors of expectancies for post-surgical pain and fatigue in breast cancer surgical patients.

Authors:  Julie B Schnur; Michael N Hallquist; Dana H Bovbjerg; Jeffrey H Silverstein; Angelina Stojceska; Guy H Montgomery
Journal:  Pers Individ Dif       Date:  2007

6.  Acute health-related quality of life outcomes and systemic inflammatory markers following contemporary breast cancer surgery.

Authors:  Arielle S Radin; Julienne E Bower; Michael R Irwin; Arash Asher; Sara A Hurvitz; Steve W Cole; Catherine M Crespi; Patricia A Ganz
Journal:  NPJ Breast Cancer       Date:  2022-08-08

7.  Symptoms and their Relationship to Disability Following Treatment for Lower Extremity Tumours.

Authors:  A M Davis; S Punniyamoorthy; A M Griffin; J S Wunder; R S Bell
Journal:  Sarcoma       Date:  1999
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.